Testing effectiveness (Phase 2)Study completedNCT01090492What this trial is testingPF-00489791 For The Treatment Of Raynaud'sWho this might be right forRaynaud's DiseasePeripheral Vascular Disease Pfizer 243
Testing effectiveness (Phase 2)Ended earlyNCT01315899What this trial is testingEfficacy of ORM-12741 for Prevention of Raynaud's PhenomenonWho this might be right forRaynaud's Phenomenon Orion Corporation, Orion Pharma 15
Post-approval studies (Phase 4)Study completedNCT03894904What this trial is testingPapaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric PatientsWho this might be right forPediatricsAnesthesiaVasospasm The University of Texas Health Science Center, Houston 100
Not applicableStudy completedNCT02202291What this trial is testingProspective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's PhenomenonWho this might be right forPrimary Raynaud's Phenomenon (PR)Genetic Mutations Causing PRStudy of Patients and Their Relatives (With or Without Primary PR) Nantes University Hospital 258
Not applicableWithdrawnNCT03490903What this trial is testingCoronary Angiography THerapeutic Virtual RealityWho this might be right forVirtual RealityAtherosclerosisCoronary Artery Disease+3 more University of California, Los Angeles
Not applicableLooking for participantsNCT05628948What this trial is testingVascular Lab Resource (VLR) BiorepositoryWho this might be right forCardiovascular DiseasesMetabolic DiseasePeripheral Artery Disease+13 more The Cleveland Clinic 500
Not applicableStudy completedNCT00619294What this trial is testingEndothelial Dysfunction and Coronary Artery SpasmWho this might be right forCoronary Vasospasm Kumamoto University 158
Very early researchStudy completedNCT05625503What this trial is testingDilution of Verapamil During Intraarterial AdministrationWho this might be right forVasospasm;PeripheralBurningPain University of Illinois at Chicago 55